Abstract: A system and method of securing artificial intelligence (AI) model based on field programmable gate array (FPGA) which is aimed at overcoming attacks against AI models by protecting the architecture of the AI model. The system includes a processor and a custom instruction hardware developed on at least one FPGA, wherein the processor and custom instruction hardware are connected via custom instruction interfaces. Through the custom instruction interfaces, the processor performs matching of an authentication key given by a user to ensure that the application is running on trusted devices while the custom instruction hardware decrypts an encrypted AI model if authentication is successful, before sending decrypted AI model to the processor to be executed in any suitable application such as AI inference.

Abstract: Disclosed are example embodiments of an exercise system and methods for providing a personalized workout session. An example method for providing a personalized workout session includes collecting heart rate data of a user during a calibration workout session. The example method for providing a personalized workout session also includes determining a plurality of personalized heart rate zones for the user based on the collected heart rate data. Additionally, the example method for providing a personalized workout session includes providing, to an exercise equipment, a workout session having a plurality of workout segments, wherein each workout segment has a target heart rate zone that is associated with one of the plurality of personalized heart rate zones.

Abstract: Disclosed are example embodiments of an exercise system and methods for providing a personalized workout session. An example method for providing a personalized workout session includes collecting heart rate data of a user during a calibration workout session. The example method for providing a personalized workout session also includes determining a plurality of personalized heart rate zones for the user based on the collected heart rate data. Additionally, the example method for providing a personalized workout session includes providing, to an exercise equipment, a workout session having a plurality of workout segments, wherein each workout segment has a target heart rate zone that is associated with one of the plurality of personalized heart rate zones.

Abstract: Embodiments provide functionality for determining fitness level of an individual using a fitness testing unit. In one such embodiment, an individual is instructed, via a graphical user interface (GUI) of a fitness testing unit, to perform a series of exercise activities. In turn, via the fitness testing unit, baseline heart rate, maximum heart rate, and recovery heart rate are captured while the individual is performing the series of exercise activities. Then, a fitness level of the individual is determined using an age of the individual and the captured baseline heart rate, maximum heart rate, and recovery heart rate.

Abstract: A fluid composition including a base fluid; and an additive composition. The additive composition includes an emulsifier; a fluid loss control agent; a rheology modifier; and a viscosifier. The fluid composition is free or substantially free of organophilic clay. The fluid composition may be used as a drilling composition.

Abstract: Embodiments provide a fitness instruction program, e.g., video and/or audio, with licensed music. One such embodiment begins by receiving a music playlist including one or more metadata tags. The metadata tags correspond to time frames of a fitness instruction program. In turn, a music station for each time frame of the fitness instruction program is identified based on the one or more metadata tags. Randomized music from each identified music station is then transmitted for playback during each of the time frames of the fitness instruction program.

Abstract: This invention relates new radiopharmaceutical conjugates for use in improved methods of diagnosis and treatment of cancer. The radiopharmaceutical conjugate comprises, in sequence: a metabolite that targets tumour cells, bound to a chelating agent capable of containing a radionuclide, bound to a linker capable of binding with an EPR agent in vitro or in vivo; or a chelating agent capable of containing a radionuclide, bound to a metabolite that targets tumour cells, bound to a linker capable of binding with an EPR agent in vitro or in vivo. The radiopharmaceutical conjugates of the present invention provide active and passive targeted radio nuclide delivery systems that can help to improve the biodistribution and pharmacological toxicity of the radiopharmaceuticals used for the diagnosis and therapy of cancer.

Abstract: A fluid composition including a base fluid; and an additive composition. The additive composition includes an emulsifier; a fluid loss control agent: a rheology modifier; and a viscosifier. The fluid composition is free or substantially free of organophilic clay. The fluid composition may be used as a drilling composition.

Abstract: This invention relates new radiopharmaceutical conjugates for use in improved methods of diagnosis and treatment of cancer. The radiopharmaceutical conjugate comprises, in sequence: a metabolite that targets tumour cells, bound to a chelating agent capable of containing a radionuclide, bound to a linker capable of binding with an EPR agent in vitro or in vivo; or a chelating agent capable of containing a radionuclide, bound to a metabolite that targets tumour cells, bound to a linker capable of binding with an EPR agent in vitro or in vivo. The radiopharmaceutical conjugates of the present invention provide active and passive targeted radio nuclide delivery systems that can help to improve the biodistribution and pharmacological toxicity of the radiopharmaceuticals used for the diagnosis and therapy of cancer.

Abstract: The present invention provides boronic acid compounds, boronic esters, and compositions thereof that can modulate apoptosis such as by inhibition of proteasome activity. The compounds and compositions can be used in methods of inducing apoptosis and treating diseases such as cancer and other disorders associated directly of indirectly with proteasome activity.

Abstract: The present invention provides boronic acid compounds, boronic esters, and compositions thereof that can modulate apoptosis such as by inhibition of proteasome activity. The compounds and compositions can be used in methods of inducing apoptosis and treating diseases such as cancer and other disorders associated directly of indirectly with proteasome activity.

Abstract: A method and apparatus for managing targeted advertisements for linear television is provided herein. During operation a client device will determine whether or not an advertisement opportunity duration is known, unknown, or variable. Based on this determination, advertisements that best match the advertisement opportunity duration will be chosen via separate algorithms. More particularly, a first algorithm will be used to choose advertisements when the advertisement opportunity duration is known, a second algorithm will be used to choose advertisements when the advertisement opportunity duration is unknown, and a third algorithm will be used to choose advertisements when the advertisement opportunity duration is variable.

Abstract: The present invention provides boronic acid compounds, boronic esters, and compositions thereof that can modulate apoptosis such as by inhibition of proteasome activity. The compounds and compositions can be used in methods of inducing apoptosis and treating diseases such as cancer and other disorders associated directly of indirectly with proteasome activity.

Abstract: Organosulfur compounds of the general formula (2) are described, wherein R1 and R2 are linear or branched C1-C5 alkyl; linear or branched C1-C5 alkenyl with the proviso that R1 is not prop-1-enyl (allyl); substituted linear or branched C1-C5 alkenyl or substituted linear or branched C1-C5 alkyl, in which the substituents are selected from OR3, NR4R5, COOR6, CON—R7R8, in which R3 is selected from H, COR9, para-methoxybenzyl and trialkylsilyl, in which R9 is alkyl or substituted alkyl; R4 N and R5 are alkyl or R4 and R5 together form a phthalimido group; R6 is alkyl or substituted alkyl; and R7 and R8 are alkyl or substituted alkyl; substituted or unsubstituted aromatic specifically where R1 and R2 are benzyl, para-methoxybenzyl and/or ortho,para-methoxybenzyl and substituted or unsubstituted heteroaromatic. The compounds can be used for inhibiting the growth of tumor cells and for treating cancer. A pharmaceutical composition and a method of preparing the compounds are also described.

Abstract: The present invention provides compounds of the structure: wherein the constituent members are defined herein, including pharmaceutical compositions thereof and methods of treating diseases therewith.

Abstract: The method for measuring porosity of concrete is a vacuum pressure saturation-based method for calculating a porosity value of a sample of concrete. The method includes the steps of first drying a concrete sample and then making a first weight measurement of the concrete sample. Following the first weight measurement, the concrete sample is placed in a vacuum pressure vessel, where the sample is subjected to vacuum. The vacuum pressure vessel and a pressure cell are next filled with water. Water in the pressure cell and vacuum pressure vessel is pressurized, and the sample remains within the pressurized water for twenty-four hours. The sample remains submerged in the vacuum pressure vessel for another twenty-four hour period to achieve equilibrium. A second weight is then taken in the water, and a third weight measurement is taken in air. The porosity is calculated based upon the first, second and third weight measurements.

Abstract: A method and apparatus for managing targeted advertisements for linear television is provided herein. During operation a list of N channels are maintained. Advertisements for the N channels are downloaded and stored locally. The list of N channels will be dynamically updated with advertisements being added to, and removed from local storage.

Abstract: A method and apparatus for managing targeted advertisements for linear television is provided herein. During operation a client device will determine whether or not an advertisement opportunity duration is known, unknown, or variable. Based on this determination, advertisements that best match the advertisement opportunity duration will be chosen via separate algorithms. More particularly, a first algorithm will be used to choose advertisements when the advertisement opportunity duration is known, a second algorithm will be used to choose advertisements when the advertisement opportunity duration is unknown, and a third algorithm will be used to choose advertisements when the advertisement opportunity duration is variable.

Abstract: The present invention provides boronic acid compounds, boronic esters, and compositions thereof that can modulate apoptosis such as by inhibition of proteasome activity. The compounds and compositions can be used in methods of inducing apoptosis and treating diseases such as cancer and other disorders associated directly of indirectly with proteasome activity.